Financial Results: Imaging Solutions

(Billions of yen)

In the Imaging Solutions segment, consolidated revenue amounted to ¥332.6 billion (down 14.0% from the previous fiscal year). Sales of consumer products such as the instax series of instant photo system and the X series of mirrorless digital cameras were affected by the impact of COVID-19 epidemic, etc.  

Consolidated operating income amounted to ¥25.1 billion (down 51.0% from the previous fiscal year) due to revenue decrease.

 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.
 

Financial Results: Healthcare & Material Solutions

(Billions of yen)

In the Healthcare & Material Solutions segment, consolidated revenue amounted to ¥1,024.2 billion (down 1.4% from the previous fiscal year). Though overall revenue decreased due to the impact of COVID-19 epidemic, healthcare increased driven by the medical systems business, bio CDMO business, regenerative medicine business, electronic materials business and recording media business.

Operating income amounted to ¥92.4 billion (down 5.3% from the previous fiscal year).

 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.
 

Financial Results: Document Solutions

(Billions of yen)

In the Document Solutions segment, consolidated revenue amounted to ¥958.3 billion (down 4.7% from the previous fiscal year) due to such factors as a negative impact of foreign exchange from depreciation of Asian currencies, a decline in exports to Europe and the United States, and the COVID-19 epidemic.

Operating income amounted to \105.0 billion (up 9.0% from the previous fiscal year) due to improved profitability from operational reforms and so on.

 

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Caution

  • These data are prepared based on the financial results reports.

  • The frequency of updates may change in accordance with changes to the format of the financial results reports.

  • Please see the financial results reports and other materials for detailed information regarding the settlement of accounts.

  • The contents of these data will not immediately reflect corrections to the financial results reports when announced.

  • While we pay due caution to the conversion of data for the posting, please note that there is a possibility that errors may occur in the information due to uncontrollable circumstances, such as the unauthorized alteration of contents by a third party or mechanical defects resulting from equipment malfunction.

  • Service provided by Nomura Investor Relations Co., Ltd.

Powered by